{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009642","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.572283+00:00","generated_at":"2026-06-01T00:06:10.406318+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Board member Jack Bech Nielsen resigns for health reasons; subsidiary Zynerba renamed","bullets":["Jack Bech Nielsen resigned from the Board effective June 27, 2024 due to health reasons; no disagreements with the company.","Wholly owned subsidiary Zynerba Pharmaceuticals, Inc. renamed to Harmony Biosciences Management, Inc. effective July 1, 2024.","No financial or operational impact disclosed from either event.","Ticker: HRMY."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009642","json":"https://secwatch.observer/filing/0001558370-24-009642.json","markdown":"https://secwatch.observer/filing/0001558370-24-009642.md","text":"https://secwatch.observer/filing/0001558370-24-009642.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000155837024009642/0001558370-24-009642-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000155837024009642/hrmy-20240627x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:06:10.406318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7a83226581","claim":"Jack Bech Nielsen resigned as Director at Harmony Biosciences Holdings, Inc..","evidence_excerpt":"On June 27, 2024, Jack Bech Nielsen notified the Board of Directors (the “Board”) of Harmony Biosciences Holdings, Inc. (the “Company”) that he is resigning from the Board effective immediately, due to health reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000155837024009642/0001558370-24-009642-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}